Benzinga··PrnewswireBrainstorm Cell Raises $1M Through Private Placement Above Current Valuation
Brainstorm Cell raised $1M via private placement at $0.60/share, above market price. Funds support Phase 3b ALS therapy trials and regulatory efforts.
BCLIprivate placementstem cell therapy